Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.8200
-0.0100 (-1.20%)
At close: Mar 27, 2026
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 479.98 million as of March 27, 2026. Its market cap has decreased by -83.56% in one year.
Market Cap
479.98M
Enterprise Value
-253.06M
Revenue
706.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.82
Market Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 479.98M, a decrease of -90.79%. That is a compound annual growth rate of -46.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 479.98M | -17.17% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 74.10B |
| Guanze Medical Information Industry (Holding) | 3.47B |
| Adicon Holdings | 2.43B |
| Mega Genomics | 1.63B |
| Kindstar Globalgene Technology | 1.09B |
| China Biotech Services Holdings | 751.31M |
| Biosino Bio-Technology and Science Incorporation | 545.55M |
| King International Investment | 142.48M |